Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Cholinergic neurotransmission (ACh precursor supply and AChE inhibition)

Cholinergic Transmission & Synthesis · Neurotransmission and synaptic plasticity

Delivers choline substrate across the blood-brain barrier to choline acetyltransferase, or competitively inhibits acetylcholinesterase, raising acetylcholine levels in the synaptic cleft and receptor occupancy.

Why it matters: The core basis of executive function, focused attention, memory consolidation and neural signaling in the brain.

Molecular targets: Choline Acetyltransferase (ChAT), AChE (acetylcholinesterase), Nicotinic and muscarinic ACh receptors

Supplements acting on this mechanism (ranked by strength and evidence)

Huperzine A

★★★★★Mechanism evidence: grade A

Huperzine A is a reversible, selective AChE inhibitor that can reduce acetylcholine breakdown. In healthy older adults given escalating oral doses, red blood cell AChE activity was suppressed, with inhibition above 50% after the last 200 μg dose. But changes in peripheral enzyme activity do not equal quantitative changes in synaptic acetylcholine in the brain, and the latter has not been measured directly in humans.

Alpha-GPC (alpha-glycerylphosphorylcholine)

★★★★☆Mechanism evidence: grade B

Alpha-GPC breaks down to release choline, which serves as a raw material for acetylcholine synthesis. A rise in free choline in human plasma supports its role as a precursor supply, but this alone does not show that acetylcholine in the synaptic cleft increases. The evidence for central cholinergic effects comes mainly from animal studies.

Bacopa monnieri extract (bacosides)

★★★☆☆Mechanism evidence: grade A

A randomized trial in 60 people observed lower plasma acetylcholinesterase activity at some time points. However, peripheral enzyme activity does not show how much the enzyme is inhibited in the brain. Changes in choline acetyltransferase in the cerebral cortex were not measured directly, and the extract used was standardized differently from this product.

Citicoline

★★★☆☆Mechanism evidence: grade B

Citicoline provides choline, which can serve as a raw material for acetylcholine and phospholipid synthesis. However, how much is actually used depends on physiological state, and choline supply is not necessarily the rate-limiting step. Human studies measured higher plasma choline, and signals from choline-containing compounds in the brain also changed. This is not enough to confirm that acetylcholine synthesis or release in the brain clearly increases at usual doses.

Soy or egg yolk lecithin (high-purity polyenylphosphatidylcholine, PC)

★★★☆☆Mechanism evidence: grade B

Oral PC can release choline during digestion, and plasma choline rose in small human studies. Choline can serve as a precursor for acetylcholine synthesis, but a rise in plasma choline does not mean more central acetylcholine. There is currently no reliable evidence that routine oral PC directly raises synaptic acetylcholine in humans.

Acetyl-L-carnitine (ALCAR)

★★★☆☆Mechanism evidence: grade C

The acetyl group carried by ALCAR is first transferred to coenzyme A and then used to make acetylcholine. ALCAR itself does not supply choline. Studies in isolated nerve tissue and in rat brain microdialysis showed that it increases acetylcholine release in some brain regions. However, the effect of standard oral doses on synaptic acetylcholine in humans is unclear.

Uridine monophosphate (UMP)

★★★☆☆Mechanism evidence: grade C

In animal experiments at exposures above typical human supplement levels, dietary UMP can increase striatal acetylcholine content and release. This suggests it may indirectly affect the cholinergic system through phospholipid metabolism. Dose and species differences are large, and human effects are not established.

Krill oil (phospholipid omega-3)

★★☆☆☆Mechanism evidence: grade B

Phosphatidylcholine can supply choline to the body. A pilot study in 17 people found that fasting plasma choline rose after 28 days of 4.5 g/day of krill oil. However, the contribution at usual doses is limited, and changes in brain acetylcholine have not been measured directly.

Phosphatidylserine (PS)

★★☆☆☆Mechanism evidence: grade C

In animal experiments, acetylcholine release in the cortex of aged rats changed after PS was given intraperitoneally, but this route differs from usual oral use. PS is not itself choline, and there is currently no reliable evidence on whether acetylcholine synthesis or release increases at synapses in humans.

Methylene blue (USP pharmaceutical grade)

★★☆☆☆Mechanism evidence: grade D

In vitro, methylene blue can inhibit cholinesterase and bind muscarinic receptors. These results come from ex vivo experiments. There is no evidence that usual oral doses raise acetylcholine in the human hippocampus or improve memory.

Open in the interactive app ›